Claims Tossed In Suit Against Biotech Company

Law360, New York (August 4, 2006, 12:00 AM EDT) -- An embattled biotech company and its disgruntled shareholders will have to go another round in court, after a California judge dismissed half the plaintiffs’ claims.

In the consolidated class action suit filed against IntraBiotics Pharmaceuticals Inc. in the U.S. District Court for the Northern District of California, a judge has dismissed the shareholder claims filed under the Securities Exchange Act of 1934.

Judge Jeffery S. White ruled that plaintiffs had not submitted enough evidence to prove that the company made a material misstatement or omission, a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.